Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204


The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice.

Reutens AT, Hutchinson R, Van Binh T, Cockram C, Deerochanawong C, Ho LT, Ji L, Khalid BA, Kong AP, Lim-Abrahan MA, Tan CE, Tjokroprawiro A, Yoon KH, Zimmet PZ, Shaw JE.

Diabetes Res Clin Pract. 2012 Oct;98(1):38-45. doi: 10.1016/j.diabres.2012.06.002. Epub 2012 Jul 10.


Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman RR, Mant D, Kinmonth AL, Neil HA; DiGEM Trial Group.

Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50. doi: 10.3310/hta13150.


A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE).

Newman SP, Cooke D, Casbard A, Walker S, Meredith S, Nunn A, Steed L, Manca A, Sculpher M, Barnard M, Kerr D, Weaver J, Ahlquist J, Hurel SJ.

Health Technol Assess. 2009 May;13(28):iii-iv, ix-xi, 1-194. doi: 10.3310/hta13280.


Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register.

Ekström N, Miftaraj M, Svensson AM, Andersson Sundell K, Cederholm J, Zethelius B, Gudbjörnsdottir S, Eliasson B.

Diabetes Obes Metab. 2012 Aug;14(8):717-26. doi: 10.1111/j.1463-1326.2012.01591.x. Epub 2012 Apr 1.


Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study.

de Sonnaville JJ, Bouma M, Colly LP, Devillé W, Wijkel D, Heine RJ.

Diabetologia. 1997 Nov;40(11):1334-40.


Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.

Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC.

Br J Clin Pharmacol. 2009 May;67(5):547-57. doi: 10.1111/j.1365-2125.2009.03391.x. Epub 2009 Feb 11.


Quality of care for patients with Type 2 diabetes mellitus--a long-term comparison of two quality improvement programmes in the Netherlands.

Renders CM, Valk GD, de Sonnaville JJ, Twisk J, Kriegsman DM, Heine RJ, van Eijk JT, van der Wal G.

Diabet Med. 2003 Oct;20(10):846-52.


Effects of lifestyle education program for type 2 diabetes patients in clinics: a cluster randomized controlled trial.

Adachi M, Yamaoka K, Watanabe M, Nishikawa M, Kobayashi I, Hida E, Tango T.

BMC Public Health. 2013 May 14;13:467. doi: 10.1186/1471-2458-13-467.


Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation.

Gray LJ, Khunti K, Williams S, Goldby S, Troughton J, Yates T, Gray A, Davies MJ; Let's Prevent Collaborators.

Cardiovasc Diabetol. 2012 May 20;11:56.


Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care.

Frei A, Herzog S, Woitzek K, Held U, Senn O, Rosemann T, Chmiel C.

Cardiovasc Diabetol. 2012 Jun 15;11:70. doi: 10.1186/1475-2840-11-70.


The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial.

Sönnichsen AC, Winkler H, Flamm M, Panisch S, Kowatsch P, Klima G, Fürthauer B, Weitgasser R.

BMC Fam Pract. 2010 Nov 5;11:86. doi: 10.1186/1471-2296-11-86.


Improving glycaemic control of patients with Type 2 diabetes in a primary care setting: a French application of the Staged Diabetes Management programme.

Varroud-Vial M, Simon D, Attali J, Durand-Zaleski I, Bera L, Attali C, Letondeur C, Strauss K, Petit C, Charpentier G.

Diabet Med. 2004 Jun;21(6):592-8.


Diabetes outcomes in specialist and general practitioner settings in Singapore: challenges of right-siting.

Wee SL, Tan CG, Ng HS, Su S, Tai VU, Flores JV, Khoo DH.

Ann Acad Med Singapore. 2008 Nov;37(11):929-35.


Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.

Östgren CJ, Sundström J, Svennblad B, Lohm L, Nilsson PM, Johansson G.

Diabet Med. 2013 May;30(5):e170-7. doi: 10.1111/dme.12145. Epub 2013 Mar 13.


Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.

Diabetes Care. 1995 Aug;18(8):1113-23.


Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care.

Goudswaard AN, Stolk RP, Zuithoff P, Rutten GE.

Eur J Epidemiol. 2004;19(6):541-5.


Therapeutic inertia in type 2 diabetes: insights from the PANORAMA study in France.

Simon D.

Diabetes Metab. 2012 Mar;38 Suppl 3:S47-52. doi: 10.1016/S1262-3636(12)71534-3.


Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.

Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, Dallosso HM, Daly H, Doherty Y, Eaton S, Fox C, Oliver L, Rantell K, Rayman G, Khunti K; Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative.

BMJ. 2008 Mar 1;336(7642):491-5. doi: 10.1136/bmj.39474.922025.BE. Epub 2008 Feb 14. Erratum in: BMJ. 2008 Apr 19;336(7649):doi:10.1136/bmj.39553.528299.AD.

Items per page

Supplemental Content

Write to the Help Desk